drugset / Trial / NCT01346319

Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.

NCT01346319

Phase 1 Completed Abbott
RandomizedParallel-groupTriple-blindTreatment

Summary

Phase 1 Dose Escalating Study of the safety, tolerability and pharmacokinetics of testosterone in hypogonadal males.

Timeline

Start
2011-04
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Undecanoate Small molecule

Indications